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Introduction: This report characterizes a syndrome of granuloma-
tous inﬁltration presenting as unexplained ventricular arrhyth-
mias with adenopathy anywhere in body. Patients without
obstructive coronary artery disease with signiﬁcant lymph nodes
were evaluated for tuberculosis and sarcoidosis. The aim of our
study is to identify the spectrum of clinical manifestations and the
various imaging features on different imaging modalities in dif-
ferent types of granulomatous cardiomyopathies and their
response to treatment.
Methods: It is a retrospective as well as prospective observational
study of all patients clinically diagnosed as granulomatous cardi-
omyopathy and subsequently conﬁrmed by imaging and standard
laboratory diagnostic test to have granuloma or granulomatous
disease elsewhere in body. Patients having ischemic heart disease
were excluded.
Results: A total of 9 patients were included with mean age of
presentation 47 years. Mediastinal adenopathy with mid-myocar-
dial scar and/or focal myocardial inﬂammation was observed in 7
patients. None of the patients had symptoms of extracardiac
disease. Evidence of tuberculosiswas present in 44.4%. Themedian
follow-up was 6 months. 8 patients had mediastinal lymphadeno-
pathy, one had axillary and one had additional extra mediastinal
lymphadenopathy.
55.5% were female, 88.8% (8 of 9 patients) had ventricular tachy-
cardia and 11.2% had complete heart block. VT recurred despite
initial treatment in 87%. Addition of disease-speciﬁc therapy abol-
ished further recurrences in 71% of them.
Conclusion: Patients with granulomatous cardiomyopathy usually
presents as unexplained ventricular arrhythmias or occasionally
atrioventricular nodal block with preserved or compromised ven-
tricular function. It is a syndrome of arrhythmogenic myocarditis
with granulomatous lymphadenopathy due to myocardial tuber-
culosis or cardiac sarcoidosis. This entity is optimally managed
with a combination of disease-speciﬁc therapy and antiarrhythmic
measures.
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Introduction: Prosthetic heart valve thrombosis (PHVT) is an
uncommon but serious complication of valve replacement. As
compared to developed countries where the reported incidence
of PHVT ranges from 0.3% to 3% per year, Indian studies have
quoted the incidence to be as high as 6% in the initial 6 months of
valve implantation. Previous studies have demonstrated variety of
risk factors [compliance to oral anticoagulation (OAC), depressed
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Baseline Features of patients with unexplained arrhythmias due to Sarcoidosis/Tuberculosis
Patient
serial No.
Age
(years)
Sex LVEF
(%)
Arrhythmia
presentation
Site of adenopathy
on imaging
Biopsy
diagnosis
Tuberculin
skin test
Diagnosis Disease speciﬁc
treatment
Antiarrhythmic
treatment
1 52 F C VT M TB P TB ATT AAD
2 35 M C VT M S N CS PDN/Mtx AAD + ICD
3 52 F C VT M GIUE P CS/TB ATT + PDN/Mtx AAD
4 42 F C VT M S N CS PDN/Mtx AAD + ICD
5 53 M C VT M S N CS PDN AAD + ICD
6 39 M No CHB M s N CS TPI + PDN –
7 41 F C VT M GIUE N CS/TB ATT + PDN AAD + ICD
8 61 F c VT M, C GIUE N CS PDN AAD + ICD
9 51 M C VT Axillary TB P TB ATT AAD
M – male, F – female, No – normal, C – compromised, VT – ventricular tachycardia, CHB – complete heart block, S – sarcoidosis, TB – tuberculosis, GIUE –
granulomatous inﬂammation of undetermine etiology, M –mediastinal, C – cervical, P – positive, N – negative, ATT – antituberculous therapy, CS – cardiac
sarcoidosis, PDN – prednisolone, Mtx – methotrexate, AAD – antiarrhythmic drug, ICD – implantable cardioverter deﬁbrillator.
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left ventricular ejection fraction (LVEF), valve prosthesis type and
position of valve, chordal preservation surgery, atrial ﬁbrillation
(AF), left atrial (LA) size] as predictor to PHVT and the outcome of
management by thrombolysis. In the current study, we intend to
evaluate whether AF is an independent predictor of PHVT.
Methods:Weprospectively collected data of all patients presenting
to our out-patient, in-patient and emergency room of department
of cardiology. All baseline parameters (demographic characteris-
tics, compliance to OAC, LVEF, valve prosthesis type and position
of valve, AF and LA size) were noted and were subjected to uni-
variate and multivariate analysis to determine their association to
PHVT.
Results: Since June 2013 to June 2015, 33 patients (20 female,
13male) with PHVT were admitted to our department. Baseline
characteristics are shown in Table 1.
Mean age of patients presenting with PHVTwas 39  12 years, with
females accounting for 2/3rd of the all PHVT patients. A total of 36
valves were thrombosed in 33 patients. Mitral valvewas affected in
28 patients and 8 patients had thrombosis of aortic valve. Mean
time duration after valve replacement till presentation with PHVT
was 4 (range 4–240)months. Mean LA diameter at was 44  16 mm.
24 (72%) of patients were in AF and overall the LVEF was almost
normal in all patients. Only 9 (25%) of patients were compliant to
the OAC prescribed.
Overall themost predominant cause of PHVT is non-compliance to
OAC.
Conclusion: Because of the inadequate number of patients with
PHVT, multivariate analysis could not be done to determine the
signiﬁcance of association of risk factors to PHVT. Overall non-
compliance to OAC appears to be the most important cause of
PHVT. AF in association is found in 72% of patients.
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Background: Stroke is a serious complication of atrial ﬁbrillation
(AF) and oral anticoagulants are effective in reducing the risk of
stroke. New oral anticoagulants (NOAC's) are available now as
alternatives.
Aims: (1) To study the clinical proﬁle of patients with AF and
attendant problems, (2) to assess the risk of stroke and bleeding
in patients with non valvar AF (NVAF) and (3) to study the fre-
quency of usage of vitamin K antagonists (VKA) and NOACs and
their attendant problems.
Methods: All consecutively hospitalized patients with AF and
those patients with AF seen in cardiology OPD were included in
this observational prospective registry study. CHA2DS2-VASc and
HASBLED scores were applied in patients with NVAF. Renal func-
tion was assessed by Cockroft–Gault formula.
Results: Of 106 patients, 56 (52.83%) were males and 50 (47.17%)
were females. The mean age was 64.67 years. 31 (29.24%) patients
had valvar AF, and 75 (70.76%) NVAF. 16 (15.09%) patients had
stroke. 51 (48.11%) had hypertension, 23 (21.69%) had diabetes, 21
(19.81%) had coronary artery disease, 5 (4.71%) had cardiomyopa-
thy, 18 (16.9%) were detected to have thyroid dysfunction and 7
(6.6%) chronic kidney disease.
The mean CHA2DS2-VASc score was 3.54, and HASBLED score was
2.11. Of 31 patients of valvar AF, 27 received VKA and 4 patients
took no anticoagulants. Out of 75 patients with NVAF, 17 received
NOAC, 29were onVKA (26 refusedNOACdue to cost constraint and
3 had creatinine clearance <30 ml/min) and 29 on antiplatelets
(CHADS score 1 or less in 5 and 24 unwilling to take anticoagulant).
3 switched to NOAC fromVKA, and 1 opted to switch fromNOAC to
VKA. Of 56 patients who were on VKA, 4 had hemorrhagic stroke. 6
patients died. No siginiﬁcant adverse effects were reported with
NOACs except one patient developed hematuria. VKA were asso-
ciated with increase risk of hemorrhagic stroke.
Conclusion:
1. NVAF was more frequent than valvar AF.
2. Antiplatelets are still being used inappropriately.
3. NOACs are attractive alternatives to VKA, but are expensive.
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The combination of ventricular tachycardia (VT) and severe left
ventricular dysfunction presents a serious challenge in manage-
ment of acute fulminant myocarditis (AFM). We present a case of a
52-year-old male with AFM, who presented with hypotension and
incessant VT not responsive to pharmacological therapy. He
underwent successful catheter ablation.
Introduction:Myocarditis is clinically and pathologically deﬁned as
‘‘inﬂammation of the myocardium’’. Clinical presentations of the
disease range from nonspeciﬁc systemic symptoms (fever, myal-
gias, palpitations, or exertional dyspnea) to fulminant hemody-
namic collapse and sudden death. Furthermore, it has been
identiﬁed as a cause of dilated cardiomyopathy in 9% of cases in
a large prospective series. Endomyocardial biopsy and autopsy
ﬁndings have clearly demonstrated that myocarditis represents
a frequent cause of life-threatening ventricular arrhythmias and
sudden death.
Electroanatomic mapping allows operators to record intracardiac
electrical activation in relation to anatomic location in a cardiac
chamber of interest, even during arrhythmia mapping. Although
use of electrophysiological ablation in AFM has not been docu-
mented widely, in exceptional cases where VT is not responding to
conventional treatment ablation remains a useful alternative.
Case:A 52-year-oldmale known case of hypertension and diabetes
mellitus since last 10 years had a history of traveling in last 15 days
following which he started experiencing fever and breathlessness.
Further, he developed swelling over his feet, abdomen and face for
which he admitted in a private hospital where he was managed
medically. But his condition went on deteriorating and he had
incessant VT for which he was given around 20 DC shock and was
intubation and IABP was inserted. 2D Echo was done which
showed global LV hypokinesia with ejection fraction of 25–30%.
He was diagnosed to be suffering from viral myocarditis and was
Table 1
Baseline characteristics n = 33
Age (mean  SD), years 39  12
Sex (M:F) 20:13
Valve at mitral position 28
Valve at aortic position 8
Time duration since valve replacement
(months, range)
34 (4–240)
LA diameter in mm (mean  SD) 44  16
Patients with AF [n (%)] 24 (72%)
LVEF (%) 58  6%
Compliance to OAC, n (%) 6 (25%)
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